- Save the Children launch website designed with CORU's help
- Attempts at surgical removal are of no benefit to asbestos cancer sufferers finds trial led by CORU's Tom Treasure
- CORU's work shows effects of selective citation on surgical practice
- Pandemic flu countermeasure work published in Vaccine
- Editorial praises CORU's simple risk stratification model
- Tom Treasure's talk is ranked among top three presentations
- The Ekjut trial in India is selected as Trial of the Year!
- Christos Vasilakis gives keynote lecture at Young OR 17 conference
- CORU informs national policy on pandemic flu
- CORU work examines the foundations of triage
- Christina Pagel gives invited talk at RCM conference
- Martin Utley gives invited talk at the MASHNET workshop
- Making sense of statistics
- UCL helps engineer to heal his own heart
- Christina Pagel has paper published in The Lancet
- Martin Utley promoted to professor
- Professor Tom Treasure attends NICE International conference
- Citation for Steve Gallivan
- NCEPOD report highlights concerns over chemotherapy
- CORU 25 year celebration
- Marfan aortic aneurysm: Golesworthy wins Healthcare Award
- CORU projections of skilled birth attendance rates in world's poorest regions published
- CORU's Skilled Birth Attendance paper is a BMC Highly Accessed paper!
- CORU's visual outcome monitoring tool (VLAD) goes global!
- Number of people living with cancer set to increase significantly
- CORU article highlights challenges in implementing modelling toolkits
- Health financing website receives positive feedback!
- Is surgery to remove secondary cancer always a good thing?
- Sonya Crowe awarded Improvement Science Fellowship by the Health Foundation!
- CORU work helps child heart teams get clearer picture of their results
- CORU's work with the Department of Health's health protection team continues
- UCL Partners successful in bid to host a new £9 million CLAHRC!
- Funding bid to understand complications following children's heart surgery successful!
- We're recruiting - make a difference to health care with CORU!
- Editorial published in Heart discussing the benefits and risks of monitoring mortality
- We are recruiting! Make a real difference to one of the UK's top hospital trusts!
- Health research partnership launches to tackle major health challenges
Citation for Steve Gallivan
19 May 2011
Professor Steve Gallivan has been awarded the 2009 Harold Larnder Prize of the Canadian Operational Research Society. The Harold Larnder Prize is awarded annually to an individual who has achieved international distinction in operational research. The prize was awarded at a ceremony which took place during the CORS-INFORMS International Meeting in Toronto in June 2009.
Steve Gallivan obtained a first class degree in mathematics from University College London (UCL) in 1971. As an undergraduate, he was fascinated by mathematics and was fortunate to secure a job in a work study department of a chain making company to support his studies. This was his first contact with OR. His PhD was concerned with generalisations of the mathematics underlying linear programming. This work was mostly carried out in UCL with a year as a visiting graduate student at the University of British Columbia. Following this, Steve joined the UK’s Transport and Road Research Laboratory, later moving to the Transport Studies Group at UCL. He worked on a variety of problems associated with traffic signal system design and control. This practical work contributed to the development of methods that are used world wide. In 1985, Dr. Gallivan was invited by the famous RRP (Ray) Jackson to join his newly formed Clinical Operational Research Unit (CORU) at UCL. After the initial “culture shock” of learning how to work in close collaboration with clinicians, he grew to thoroughly enjoy this productive and rewarding area of OR. He has worked on projects in a wide range of clinical areas. These include cardiac surgery, cardiology, cancer, genetic screening, primary health care, mental health, rheumatology, pharmacy, gynaecology, obstetrics, public health, hospital safety, infection control and health service operation.
Dr. Gallivan has co-authored over 200 publications. These have included papers in pure mathematics, transport science and operational research journals. He has a substantial number of publications in the medical press, the domain where the work has had the most impact. There have been many tangible results from his research. Work on cervical cancer screening has been used for evaluating numerous screening options and, more recently, vaccination policies. The modelling of ante-natal genetic screening has been used in an empirical study related to screening for haemoglobinopathies. CORU’s hospital capacity modelling has been used in several contexts and is being extended by another research group.
The research for which he is most well known concerns the development of analytical methods for monitoring adverse clinical events, particularly post-operative deaths. CORU developed a monitoring tool known as VLAD that can be used to give a graphical summary of clinical outcomes for a single surgeon or unit. This is adjusted to take due account of the risk profile of cases to avoid penalizing surgeons whose case load is intrinsically complex. Originally developed in the context of adult cardiac surgery at a single centre, the method has been adopted by clinicians within the UK and worldwide. It is in routine use in many cardiac surgery centres and has been extended for use in the context of myocardial infarction and congenital heart surgery. Indeed, a practitioner from Australia has written a book to accompany the method called “VLADs for dummies”.